A case of neurotoxicity following 5-fluorouracil-based chemotherapy
- PMID: 12014219
- PMCID: PMC4531646
- DOI: 10.3904/kjim.2002.17.1.73
A case of neurotoxicity following 5-fluorouracil-based chemotherapy
Abstract
5-Fluorouracil (5-FU) is a commonly used chemotherapeutic agent. However, its neurotoxicity is rare and not well recognized. We report a case of 5-FU neurotoxicity with organic brain syndrome and progression to multifocal leukoencephalopathy in a 44-year-old male patient having malignant gastrointestinal stromal tumor. 5-FU-induced neurotoxicity should, therefore, be considered as an important differential diagnosis in cancer patients with neurological abnormality and history of chemotherapy.
Figures
References
-
- Moore DH, Fowler WC, Jr, Crumpler LS. Case report, 5-fluorouracil neurotoxicity. Gynecol Oncol. 1990;36:152–154. - PubMed
-
- Pizada NA, Ali II, Dafer RM. Fluorouracil-induced neurotoxicity. Ann Pharmacother. 2000;34:35–38. - PubMed
-
- Shehata N, Pater A, Tang SC. Prolonged severe 5-fluorouracil associated neurotoxicity in a patient with dihydropyrimidine dehydrogenase deficiency. Cancer Investig. 1999;17:201–205. - PubMed
-
- Riehl JL, brown WJ. Acute cerebellar syndrome secondary to 5-fluorouracil therapy. Neurology. 1964;14:961–967. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources